Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Lindquist

Showing results (181-190 of 191) with videos related to

Pageof 20
Sort By:
Plos Medicine|January 24, 2023
School-age outcomes among IVF-conceived children: A population-wide cohort studyAmber L Kennedy, Beverley J Vollenhoven, Richard J Hiscock, et al.
Scientific Reports|June 12, 2019
Targeting CLDN18.2 by CD3 Bispecific and ADC Modalities for the Treatments of Gastric and Pancreatic CancerGuoyun Zhu, Davide Foletti, Xiaohui Liu, et al.
Scientific Reports|November 9, 2019
Author Correction: Targeting CLDN18.2 by CD3 Bispecific and ADC Modalities for the Treatments of Gastric and Pancreatic CancerGuoyun Zhu, Davide Foletti, Xiaohui Liu, et al.
Nature Biotechnology|July 9, 2015
Site-specific conjugation improves therapeutic index of antibody drug conjugates with high drug loadingPavel Strop, Kathy Delaria, Davide Foletti, et al.
BMC Medicine|April 1, 2025
School-age outcomes among IVF and ICSI-conceived children: a causal inference analysis using linked population-wide dataAmber L Kennedy, Richard J Hiscock, Beverley J Vollenhoven, et al.
Journal of Molecular Biology|May 1, 2012
Generating bispecific human IgG1 and IgG2 antibodies from any antibody pairPavel Strop, Wei-Hsien Ho, Leila M Boustany, et al.
Analytical Biochemistry|March 28, 2006
Kinetic analysis of a high-affinity antibody/antigen interaction performed by multiple Biacore usersPhinikoula S Katsamba, Iva Navratilova, Maria Calderon-Cacia, et al.
Molecular Cancer Therapeutics|August 23, 2019
Preclinical Efficacy and Safety Comparison of CD3 Bispecific and ADC Modalities Targeting BCMA for the Treatment of Multiple MyelomaSiler H Panowski, Tracy C Kuo, Yi Zhang, et al.
The Protein Journal|August 1, 2022
Evolution of Stronger SARS-CoV-2 Variants as Revealed Through the Lens of Molecular Dynamics SimulationsAlec J Wozney, Macey A Smith, Mobeen Abdrabbo, et al.
Protein Science : a Publication of the Protein Society|September 24, 2021
Vitamin D and COVID-19: A review on the role of vitamin D in preventing and reducing the severity of COVID-19 infectionMobeen Abdrabbo, Cole M Birch, Michael Brandt, et al.
Pageof 20

Showing results (181-190 of 191) with videos related to

Sort By:
Pageof 20
Plos Medicine|January 24, 2023
School-age outcomes among IVF-conceived children: A population-wide cohort studyAmber L Kennedy, Beverley J Vollenhoven, Richard J Hiscock, et al.
Scientific Reports|June 12, 2019
Targeting CLDN18.2 by CD3 Bispecific and ADC Modalities for the Treatments of Gastric and Pancreatic CancerGuoyun Zhu, Davide Foletti, Xiaohui Liu, et al.
Scientific Reports|November 9, 2019
Author Correction: Targeting CLDN18.2 by CD3 Bispecific and ADC Modalities for the Treatments of Gastric and Pancreatic CancerGuoyun Zhu, Davide Foletti, Xiaohui Liu, et al.
Nature Biotechnology|July 9, 2015
Site-specific conjugation improves therapeutic index of antibody drug conjugates with high drug loadingPavel Strop, Kathy Delaria, Davide Foletti, et al.
BMC Medicine|April 1, 2025
School-age outcomes among IVF and ICSI-conceived children: a causal inference analysis using linked population-wide dataAmber L Kennedy, Richard J Hiscock, Beverley J Vollenhoven, et al.
Journal of Molecular Biology|May 1, 2012
Generating bispecific human IgG1 and IgG2 antibodies from any antibody pairPavel Strop, Wei-Hsien Ho, Leila M Boustany, et al.
Analytical Biochemistry|March 28, 2006
Kinetic analysis of a high-affinity antibody/antigen interaction performed by multiple Biacore usersPhinikoula S Katsamba, Iva Navratilova, Maria Calderon-Cacia, et al.
Molecular Cancer Therapeutics|August 23, 2019
Preclinical Efficacy and Safety Comparison of CD3 Bispecific and ADC Modalities Targeting BCMA for the Treatment of Multiple MyelomaSiler H Panowski, Tracy C Kuo, Yi Zhang, et al.
The Protein Journal|August 1, 2022
Evolution of Stronger SARS-CoV-2 Variants as Revealed Through the Lens of Molecular Dynamics SimulationsAlec J Wozney, Macey A Smith, Mobeen Abdrabbo, et al.
Protein Science : a Publication of the Protein Society|September 24, 2021
Vitamin D and COVID-19: A review on the role of vitamin D in preventing and reducing the severity of COVID-19 infectionMobeen Abdrabbo, Cole M Birch, Michael Brandt, et al.
Pageof 20